The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 18,101–18,200 of 31,469
Jalali, S., Zareshahi, N., Behnoush, A. H., Azarboo, A., Shirinezhad, A., Hosseini, S. Y., Javidan, A., & Raeini, A. G. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01317-4 · Cited by 15
Virtanen, J. K., Hantunen, S., Kallio, N., Lamberg-Allardt, C. J. E., Manson, J. E., Nurmi, T., Pihlajamäki, J., Uusitupa, M. I. J., Voutilainen, A., & Tuomainen, T. (2024) · Diabetologia · doi:10.1007/s00125-024-06336-9 · Cited by 15
Metabolic Syndrome and Insulin Resistance in Romania
Ștefan, A. G., Clenciu, D., Mitrea, A., Vladu, I. M., Timofticiuc, D. C. P., Roşu, M. M., Maria, D. T., Dinu, R., Gheonea, T. C., Vladu, B. E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062389 · Cited by 16
Ruiz‐Canela, M., Corella, D., Martínez‐González, M. Á., Babió, N., Martínez, J. A., Forga, L., Alonso‐Gómez, Á. M., Wärnberǵ, J., Vioqué, J., Romaguera, D., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-00388 · Cited by 18
Tryggestad, J. B., Thompson, D. M., Copeland, K. C., & Short, K. R. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12017 · Cited by 14
Síndrome de resistencia a la insulina. estudio y manejo
Fernando Carrasco, N., Galgani, F. J. E., & Reyes, J. M. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70230-x · Cited by 20
Effect of Chinese herbal medicine on vascular functions during 60-day head-down bed rest
Yuan, M., Alameddine, A., Coupé, M., et al. (2015) · European Journal of Applied Physiology · doi:10.1007/s00421-015-3176-y · Cited by 14
Pavlik, V., Massman, P. J., Barber, R. C., & Doody, R. S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121999 · Cited by 14
Chou, C.-H., Tsai, W., Wang, M.-C., et al. (2013) · International Heart Journal · doi:10.1536/ihj.54.27 · Cited by 14
Zhang, X., Liu, T., Wang, Y., Zhong, M., Zhang, G., Liu, S., Wu, T., Rayner, C. K., & Hu, S. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1925-y · Cited by 14
Heritability of the risk factors characteristic for the metabolic syndrome: a twin study
Jermendy, G., Littvay, L., Steinbach, R., Jermendy, Á. L., Tárnoki, Á. D., Tárnoki, D. L., Métneki, J., & Osztovits, J. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29165 · Cited by 14
Li, M., Li, H., Zhou, Z., Zhou, Y., Wang, Y., Zhang, X., Liu, T., Zhong, M., Han, H., Liu, S., et al. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1816-2 · Cited by 14
Kirkegaard, H., Nohr, E. A., Rasmussen, K. M., Støvring, H., Sørensen, T. I. A., Lewis, C. E., & Gunderson, E. P. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.099184 · Cited by 14
Non-invasive assessment of endothelial function in children with obesity and lipid disorders
Hudgins, L. C., Annavajjhala, V., Kovanlıkaya, A., Frank, M., Solomon, A. B., Parker, T. S., & Cooper, R. (2015) · Cardiology in the Young · doi:10.1017/s1047951115000657 · Cited by 14
Samaras, K., Crawford, J., Baune, B., Campbell, L. V., Smith, E., Lux, O., Brodaty, H., Trollor, J. N., & Sachdev, P. S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04105.x · Cited by 14
Effects of fluvastatin on insulin resistance and cardiac morphology in hypertensive patients
Teixeira, A. A. D. S., Buffani, A., Tavares, A., Ribeiro, A. B., Zanella, M. T., Kohlmann, O., & Batista, M. C. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.87 · Cited by 14
Two years of growth hormone replacement therapy in a group of patients with Sheehan’s syndrome
Soares, D. V., Spina, L. D. C., Brasil, R. R. L. O., Lobo, P. M., Salles, E. F., Coeli, C. M., Conceição, F. L., & Vaisman, M. (2006) · Pituitary · doi:10.1007/s11102-006-9990-9 · Cited by 14
Monteiro, C. M. C., Pinheiro, L. F., Izar, M. C. D. O., Barros, S. W., Vasco, M. B., Fischer, S. M., Póvoa, R., Brandão, S. A. B., dos Santos, A. O., Oliveira, L. J. G. D., et al. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010005000008 · Cited by 15
Kizer, J. R., Umans, J. G., Zhu, J., Devereux, R. B., Wolfert, R. L., Lee, E. T., & Howard, B. V. (2012) · Diabetes Care · doi:10.2337/dc11-1639 · Cited by 14
Xu, Z. R., Molyneaux, L. M., Wang, Y., et al. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00137.x · Cited by 14
Poomthavorn, P., Nantarakchaikul, P., Mahachoklertwattana, P., Chailurkit, L., & Khlairit, P. (2013) · Clinical Endocrinology · doi:10.1111/cen.12337 · Cited by 14
Okuma, H., Okada, T., Abe, Y., Saito, E., Iwata, F., Hara, M., Ayusawa, M., Mugishima, H., & Takahashi, S. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.07.019 · Cited by 14
Zhou, J., Zhu, Y., Chen, Z., Mo, J., Xie, F.-Z., Wen, Y.-H., Guo, P., Peng, J., Xu, J. F., Wang, J., et al. (2014) · Public Health Nutrition · doi:10.1017/s1368980014002845 · Cited by 14
Randell, P. A., Jackson, A., Boffito, M., Back, D. J., Tjia, J. F., Taylor, J., Mandalia, S., & Moyle, G. J. (2010) · Antiviral Therapy · doi:10.3851/imp1675 · Cited by 14
Vitamin D and Insulin Resistance in Non-Diabetic Women's Interagency HIV Study Participants
Adeyemi, O. M., Livak, B., Orsi, J. M., Glesby, M. J., Villacres, M. C., Weber, K. M., Sharma, A., Golub, E. T., Young, M., Cohen, M. H., et al. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0400 · Cited by 15
Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada)
Borugian, M. J., Spinelli, J. J., Gordon, P. B., Abanto, Z. U., Brooks-Wilson, A. R., Pollak, M., Warren, L. J., Hislop, T. G., & Gallagher, R. P. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0339-9 · Cited by 14
Guadalupe‐Grau, A., Ara, I., Dorado, C., Vicente‐Rodríguez, G., Pérez‐Gómez, J., Cabrero, J. C., Serrano, J. A., Santana, A., & Calbet, J. A. L. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1550-3 · Cited by 14
Diagnostic Criteria for Metabolic Syndrome: Caucasians Versus African-Americans
Zeno, S. A., Deuster, P. A., Davis, J. L., Kim-Dorner, S.-J., Remaley, A. T., & Poth, M. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0053 · Cited by 14
Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China
Ren, Q., Han, X., Tang, Y., Zhang, X., Zou, X., Cai, X., Zhang, S., Zhang, L., Li, H., & Ji, L. (2013) · Diabetologia · doi:10.1007/s00125-013-3146-z · Cited by 14
Agamia, N., & Gomaa, S. H. (2014) · Egyptian Journal of Dermatology and Venerology · doi:10.4103/1110-6530.137314 · Cited by 14
Adiponectin is associated with serum and adipose tissue fatty acid composition in rats
de Heredia, F. P., Sánchez, J., Priego, T., Larqué, E., Portillo, M. P., Palou, A., Zamora, S., & Garaulet, M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345737 · Cited by 14
Bakoma, B., Berke, B., Eklu‐Gadegbeku, K., et al. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.03.065 · Cited by 14
Intzilakis, T., Hartmann, G., Mouridsen, M. R., Eugen‐Olsen, J., Kumarathurai, P., Madsbad, S., Almdal, T., Haugaard, S. B., & Sajadieh, A. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12070 · Cited by 13
Aasen, G., Fagertun, H., & Halse, J. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510902778734 · Cited by 14
Immediate Metabolic Response Following Sleeve Gastrectomy in Obese Diabetics
Meydan, C., Goldstein, N., Weiss-Shwartz, E., Lederfine, D., Goitein, D., Rubin, M., & Spivak, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1669-8 · Cited by 14
Glycaemic load is associated with insulin resistance in older Australian women
O’Sullivan, T. A., Bremner, A., O'Neill, S., & Lyons‐Wall, P. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.115 · Cited by 14
Adolescent and Young Adult Female Determinants of Visceral Adipose Tissue at Ages 26-28 Years
Glueck, C. J., Wang, P., Woo, J. G., Morrison, J. A., Khoury, P. R., & Daniels, S. R. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.12.030 · Cited by 14
Matayoshi, T., Kamide, K., Takiuchi, S., et al. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960701616186 · Cited by 14
Baburao, A., & Souza, G. D. (2014) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.143280 · Cited by 14
Low cardio/respiratory fitness as an independent predictor of metabolic syndrome in Korean young men
Lee, J., Kim, S., & Kang, H. (2009) · European Journal of Applied Physiology · doi:10.1007/s00421-009-1251-y · Cited by 14
Park, S., Kim, M., & Kim, S. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2540 · Cited by 16
The risky body mass index ranges for significant hepatitis B viral load: A campus-based study
Chiang, C., Lai, J., Sheu, J., Yen, L.-L., Liu, C., & Huang, K. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.04.005 · Cited by 14
Dimitroulas, T., Sandoo, A., Hodson, J. A., Smith, J., Panoulas, V. F., & Kitas, G. D. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.07.033 · Cited by 14
Shibasaki, S., Eguchi, K., Matsui, Y., Ishikawa, J., Hoshide, S., Ishikawa, S., Kabutoya, T., Pickering, T. G., Shimada, K., & Kario, K. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832a6d6a · Cited by 14
Miyazaki, R., Kotani, K., Tsuzaki, K., Sakane, N., Yonei, Y., & Ishii, K. (2013) · Asia Pacific Journal of Public Health · doi:10.1177/1010539513506603 · Cited by 14
de Oliveira, L. P. M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i18.2203 · Cited by 14
de Luis, D. A., Izaola, O., de la Fuente, B., & Aller, R. (2014) · PubMed · doi:10.3305/nh.2014.30.4.7864 · Cited by 14
Mansuri, S., Badawi, A. F., Kayaniyil, S., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.017 · Cited by 14
Henninger, J., Hammarstedt, A., Rawshani, A., & Eliasson, B. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0048-8 · Cited by 15
Wijesuriya, M., Gulliford, M. C., Vasantharajah, L., Viberti, G. C., Gnudi, L., & Karalliedde, J. J. (2011) · Trials · doi:10.1186/1745-6215-12-209 · Cited by 14
Milagros Espinoza, Z., Nelina Ruiz, F., Barrios, E., Reigosa, A., Herrera, U. L., & González, J. C. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009000900006 · Cited by 13
Ji, B., Li, R., Zhang, S., Gong, L., Wang, Z., Ren, W., & Li, Q. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.019 · Cited by 13
Shioji, K., Izuhara, M., Mitsuoka, H., Uegaito, T., Matsuda, M., & the Kishiwada Atherosclerosis Prevention Study (KAPS) Group (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12066 · Cited by 14
Chiu, K., Chuang, L., Chu, A. Y., Yoon, C., & Wang, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480641 · Cited by 14
Kruszelnicka, O., Surdacki, A., & Golay, A. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-145 · Cited by 14
Enhanced Cardiovascular Risk and Altered Oxidative Status in Elders with Moderate Excessive Body Fat
Narotzki, B., Reznick, A. Z., Mitki, T., Aizenbud, D., & Levy, Y. (2014) · Rejuvenation Research · doi:10.1089/rej.2013.1540 · Cited by 14
Brener, M. I., Post, W. S., Haberlen, S., Zhang, L., Palella, F. J., Jacobson, L. P., Dobs, A. S., George, R. T., Witt, M. D., Budoff, M. J., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.037 · Cited by 14
Ko, J. K. Y., Li, R., Lam, K. S. L., Tam, S., Lee, V. C. Y., Yeung, T. W. Y., Ho, P. C., & Ng, E. H. Y. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1126708 · Cited by 14
Geidenstam, N., Danielsson, A. P. H., Spégel, P., & Ridderstråle, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.12.024 · Cited by 15
Kim, J. Y., Lee, C., Oh, M., Im, J.-A., Lee, J., Chu, S. H., Lee, H., & Jeon, J. Y. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.03.018 · Cited by 14
Yerlikaya, F., Toker, A., Çiçekler, H., & Arıbaş, A. (2014) · Biotechnic & Histochemistry · doi:10.3109/10520295.2014.937744 · Cited by 14
Díaz‐Rúa, R., van Schothorst, E. M., Keijer, J., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.47 · Cited by 14
Bezrati, I., Fradj, M. K. B., Ouerghi, N., et al. (2016) · Libyan Journal of Medicine · doi:10.3402/ljm.v11.31258 · Cited by 14
Association of Urinary Sodium Excretion With Insulin Resistance in Korean Adolescents
Chun, Y. H., Han, K., Kim, D., Park, Y. G., Cho, K.-H., Choi, Y. S., Kim, S. M., Kim, Y., & Nam, G. E. (2016) · Medicine · doi:10.1097/md.0000000000003447 · Cited by 14
Correlation of Lipid Parameters and Markers of Insulin Resistance: Does Smoking Make a Difference?
Cibičková, Ľ., Karásek, D., Langová, K., Vaverková, H., Orság, J., Lukeš, J., & Novotný, D. (2014) · Physiological Research · doi:10.33549/physiolres.932869 · Cited by 14
Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype
Guglielmi, V., Maresca, L., Lanzillo, C., Marinoni, G. M., D’Adamo, M., Roma, M. D., Preziosi, P., Bellia, A., Calò, L., & Sbraccia, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158892 · Cited by 14
Holwerda, S. W., Reynolds, L. J., Restaino, R. M., Credeur, D. P., Leidy, H. J., Thyfault, J. P., & Fadel, P. J. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00584.2015 · Cited by 15
Hamed, S. A., Youssef, A. H., Elserogy, Y. E., Herdan, O. M., Abd-Elaal, R. F., Metwaly, N. A., Hassan, M. M., & Mohamad, H. O. (2013) · Journal of Neurology and Neuroscience · Cited by 14
Understanding the sensitivity of muscle protein synthesis to dairy protein in middle-aged men
Mitchell, C. J., D’Souza, R. F., Zeng, N., McGregor, R. A., Fanning, A. C., Poppitt, S. D., & Cameron‐Smith, D. (2016) · International Dairy Journal · doi:10.1016/j.idairyj.2016.07.008 · Cited by 14
Incompatibility between fasting and postprandial plasma glucose in patients with Cushing’s syndrome
Otsuki, M., Kitamura, T., Tamada, D., Tabuchi, Y., Mukai, K., Morita, S., Kasayama, S., Shimomura, I., & Koga, M. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej15-0748 · Cited by 14
James, A. P., Whiteford, J., Ackland, T. R., Dhaliwal, S. S., Woodhouse, J. J., Prince, R. L., Meng, X., & Kerr, D. A. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3465-0 · Cited by 14
What to expect from an evolutionary hypothesis for a human disease: The case of type 2 diabetes
Watve, M., & Diwekar-Joshi, M. (2016) · HOMO · doi:10.1016/j.jchb.2016.07.001 · Cited by 15
Liao, S., Vickers, M. H., Evans, A., Stanley, J. L., Baker, P. N., & Perry, J. K. (2016) · Endocrine · doi:10.1007/s12020-016-1060-0 · Cited by 13
Qian, W., Cai, X., Zhang, X., et al. (2016) · PubMed · Cited by 14
Tracking weight change, insulin resistance, stress, and aerobic fitness over 4 years of college
Hopper, M. K., & Moninger, S. L. (2016) · Journal of American College Health · doi:10.1080/07448481.2016.1238385 · Cited by 14
Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome
Çelik, E., Türkçüoğlu, İ., Ata, B., Karaer, A., Kirici, P., Eraslan, S., Taşkapan, Ç., & Berker, B. (2016) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2016.16133 · Cited by 14
Paula, R., de Souza, V. C., Machado‐Silva, W., Almeida, B. R. S., Darós, A. C., Gomes, L., Ferreira, A. P., Brito, C. J., Córdova, C., Moraes, C. F., et al. (2016) · Clinics · doi:10.6061/clinics/2016(12)09 · Cited by 14
Kim, H. J., Bae, J. C., Park, H. K., Byun, D. W., Suh, K., Yoo, M. H., Jee, J. H., Kim, J. H., Min, Y., Kim, S. W., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0734 · Cited by 14
Åkerman, L., Ludvigsson, J., Swartling, U., & Casas, R. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2900 · Cited by 14
Gozal, D., Khalyfa, A., Qiao, Z., Smith, D. L., Philby, M. F., Koren, D., & Kheirandish‐Gozal, L. (2017) · Obesity · doi:10.1002/oby.21859 · Cited by 14
Salazar, M. R., Espeche, W. G., Stavile, R. N., et al. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx096 · Cited by 14
Radetti, G., Grugni, G., Lupi, F., Marazzi, N., Longhi, S., Fanolla, A., & Sartório, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0705-z · Cited by 15
Min, S. H., Kong, S. H., Lee, J.-E., Lee, D., Oh, T. J., Kim, K. M., Park, K. S., Jang, H. C., & Lim, S. K. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.07.002 · Cited by 15
Plasma GDF15 level is elevated in psychosis and inversely correlated with severity
Kumar, P., Millischer, V., Villaescusa, J. C., Nilsson, I. A. K., Östenson, C., Schalling, M., Ösby, U., & Lavebratt, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-07503-2 · Cited by 16
High Intensity Exercise: Can It Protect You from A Fast Food Diet?
Duval, C., Rouillier, M.-A., RABASA-LHORET, R. P. R., & Karelis, A. D. (2017) · Nutrients · doi:10.3390/nu9090943 · Cited by 18
Chen, X., Wu, W., Wang, L., Shi, Y., Shen, F., Gu, X., & Jia, Z. (2017) · Medical Science Monitor · doi:10.12659/msm.904755 · Cited by 14
Change in visceral adiposity is an independent predictor of future arterial pulse pressure
Han, S. J., Fujimoto, W. Y., Kahn, S. E., Leonetti, D. L., & Boyko, E. J. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001532 · Cited by 14
Joatar, F. E., Qarni, A. A. A., Ali, M. E., et al. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.3.360 · Cited by 14
Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths
Parrinello, C. M., Rudolph, B., Lazo, M., Gallo, L. C., Thyagarajan, B., Cotler, S. J., Qi, Q., Seeherunvong, T., Vidot, D. C., Strickler, H. D., et al. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000946 · Cited by 14
Diet and cardiometabolic side effects in children treated with second-generation antipsychotics
Barker, M. K., Sable, C. M., Montgomery, S. E., Chow, L., Green, T., Panagiotopoulos, C., & Devlin, A. M. (2017) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2017.09.013 · Cited by 14
Argan Oil as an Effective Nutri-Therapeutic Agent in Metabolic Syndrome: A Preclinical Study
Midaoui, A. E., Haddad, Y., Filali-Zegzouti, Y., & Couture, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112492 · Cited by 15
de la Fuente, R. A., Cuadrado, N. M., Sánchez, C. N. T., et al. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.12.011 · Cited by 14
The characteristics of small intestinal bacterial overgrowth in patients with gallstone diseases
Kim, D. B., Paik, C. N., Song, D. S., Kim, Y. J., & Lee, J. M. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14113 · Cited by 15
Takagi, Y., Sugimoto, T., Kobayashi, M., Shirai, M., & Asai, F. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3671892 · Cited by 15
Tapia, G., Silva, D., Romero, N., Pettinelli, P., Dossi, C. G., de Miguel, M., & Gonzalez‐Mañán, D. (2018) · Nutrition · doi:10.1016/j.nut.2018.01.012 · Cited by 14
Manjarín, R., Columbus, D. A., Solis, J., Hernandez‐Garcia, A., Suryawan, A., Nguyen, H. V., McGuckin, M. M., Jiménez, R., Fiorotto, M. L., & Davis, T. A. (2018) · Amino Acids · doi:10.1007/s00726-018-2572-0 · Cited by 14
Huh, J. H., Lee, M., Park, S. Y., et al. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.0091 · Cited by 14
Okura, T., Nakamura, R., Fujioka, Y., Kitao, S., Ito, Y., Matsumoto, K., Shoji, K., Sumi, K., Matsuzawa, K., Izawa, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197663 · Cited by 14
Wang, X., Zhou, Y., Zhang, M., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.07.003 · Cited by 14
Golzar, F. A.-K., Fathi, R., & Mahjoub, S. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0307 · Cited by 14
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
